Quality of Life and Technology: Impact on Children and Families With Diabetes

被引:45
作者
Hirose, Masakazu [1 ,2 ]
Beverly, Elizabeth A. [1 ,2 ]
Weinger, Katie [1 ,2 ]
机构
[1] Joslin Diabet Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
基金
美国国家卫生研究院;
关键词
Adolescents; Children; Quality of life; Type; 1; diabetes; Continuous glucose monitoring; Continuous subcutaneous insulin infusion; Insulin pump; Technology; SUBCUTANEOUS INSULIN INFUSION; MULTIPLE DAILY INJECTIONS; RANDOMIZED CONTROLLED-TRIAL; GLUCOSE MONITORING-SYSTEM; PATIENT-REPORTED OUTCOMES; PUMP THERAPY; METABOLIC-CONTROL; GLYCEMIC CONTROL; YOUNG-CHILDREN; SELF-MANAGEMENT;
D O I
10.1007/s11892-012-0313-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ensuring quality of life (QOL) while maintaining glycemic control within targets is an important challenge in type 1 and type 2 diabetes treatment. For children with diabetes, QOL includes enjoying meals, feeling safe in school, and perceiving positive, supportive relationships with parents, siblings, and friends. Yet many treatment-related and psychosocial barriers can interfere with a child's QOL and their ability to manage diabetes effectively. Diabetes management also imposes considerable lifestyle demands that are difficult and often frustrating for children to negotiate at a young age. Recent advances in diabetes medications and technologies have improved glycemic control in children with diabetes. Two widely used technologies are the insulin pump and continuous glucose monitoring (CGM) system. These technologies provide patients with more flexibility in their daily life and information about glucose fluctuations. Several studies report improvements in glycemic control in children with type 1 diabetes using the insulin pump or sensor-augmented pump therapy. Importantly, these technologies may impact QOL for children and families with diabetes, although they are rarely used or studied in the treatment of children with type 2 diabetes. Further, emerging closed loop and web- and phone-based technologies have great potential for supporting diabetes self-management and perhaps QOL. A deeper understanding and appreciation of the impact of diabetes technology on children's and parents' QOL is critical for both the medical and psychological care of diabetes. Thus, the purpose of this review is to discuss the impact of new diabetes technologies on QOL in children, adolescents and families with type 1 diabetes.
引用
收藏
页码:711 / 720
页数:10
相关论文
共 113 条
[81]   The DAWN Youth WebTalk Study: methods, findings, and implications [J].
Peyrot, Mark .
PEDIATRIC DIABETES, 2009, 10 :37-45
[82]   Use of insulin pediatric pump therapy in the age-group - Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes [J].
Phillip, Moshe ;
Battelino, Tadej ;
Rodriguez, Henry ;
Danne, Thomas ;
Kaufman, Francine .
DIABETES CARE, 2007, 30 (06) :1653-1662
[83]   Continuous subcutaneous insulin infusion at 25 years - Evidence base for the expanding use of insulin pump therapy in type 1 diabetes [J].
Pickup, J ;
Keen, H .
DIABETES CARE, 2002, 25 (03) :593-598
[84]   Insulin-Pump Therapy for Type 1 Diabetes Mellitus [J].
Pickup, John C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (17) :1616-1624
[85]   Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data [J].
Pickup, John C. ;
Freeman, Suzanne C. ;
Sutton, Alex J. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
[86]   Home telehealth for diabetes management: a systematic review and meta-analysis [J].
Polisena, J. ;
Tran, K. ;
Cimon, K. ;
Hutton, B. ;
McGill, S. ;
Palmer, K. .
DIABETES OBESITY & METABOLISM, 2009, 11 (10) :913-930
[87]  
Ramchandani Neesha, 2011, J Diabetes Sci Technol, V5, P860
[88]   Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes - A randomized, parallel-group, 24-week study [J].
Raskin, P ;
Bode, BW ;
Marks, JB ;
Hirsch, IB ;
Weinstein, RL ;
McGill, JB ;
Peterson, GE ;
Mudaliar, SR ;
Reinhardt, RR .
DIABETES CARE, 2003, 26 (09) :2598-2603
[89]   Perceptions of psychosocial factors and the insulin pump [J].
Ritholz, Marilyn D. ;
Smaldone, Arlene ;
Lee, Jarim ;
Castillo, Astrid ;
Wolpert, Howard ;
Weinger, Katie .
DIABETES CARE, 2007, 30 (03) :549-554
[90]   SUPPORTIVE AND NONSUPPORTIVE FAMILY BEHAVIORS - RELATIONSHIPS TO ADHERENCE AND METABOLIC CONTROL IN PERSONS WITH TYPE-I DIABETES [J].
SCHAFER, LC ;
MCCAUL, KD ;
GLASGOW, RE .
DIABETES CARE, 1986, 9 (02) :179-185